Technique for preparing double-acetyl emodic acid sustained-release capsules
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 上海慈瑞医药科技股份有限公司
- Publication Date
- 2010-09-15
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a preparation process of a diacetylrhein sustained-release capsule, which is used for treating symptoms such as pain and joint dysfunction caused by degenerative arthritis and related diseases, and belongs to the technical field of pharmacy. Background technique
[0002] Diacetylrhein, chemical name 4,5-diacetyl-9,10-dihydro-9,10 dioxo-2-anthracene carboxylic acid, also known as diacerein (Diacerein), is osteoarthritis IL-1 Inhibitor, can induce cartilage production, has analgesic, anti-inflammatory and antipyretic effects. It is clinically used to treat symptoms such as pain and joint dysfunction caused by degenerative arthritis and related diseases.
[0003] The currently clinically used diacetyl rhein preparations are mainly ordinary tablets and ordinary capsules. The drug release rate of these two common capsules belongs to normal release, in order to ensure the effective blood drug concentration, it needs to be taken twi...